Glucotrack completed its Merger with Lokahi Therapeutics and added unaudited financial information through June 30, 2026, alongside audited statements for 2025 and 2024. The pro forma data gives investors a combined view of Glucotrack and Lokahi, including a Balance Sheet at June 30, 2026 and operations assuming a January 1 closing.

Key Highlights

  • The combined balance sheets assume the merger took place on June 30, 2026, while operating statements use a January 1 closing assumption.
  • Glucotrack, Inc. completed its merger with Lokahi Therapeutics Inc.
  • The materials add financial information covering June 30, 2026.
  • Pro forma combined balance sheets are presented as of June 30, 2026, as though the merger occurred on that date.

Merger Completion

Glucotrack, Inc. completed its merger with Lokahi Therapeutics Inc., according to the article. The completed transaction is the central event underlying the financial materials described in the filing-related update.

The article identifies Glucotrack by its Nasdaq ticker, GCTK, and names Lokahi Therapeutics Inc. as the company involved in the merger. It does not provide additional transaction terms, consideration details, or operational information.

Financial Information

The materials add financial information covering June 30, 2026. That information is presented in connection with the completed merger between Glucotrack and Lokahi.

The article specifically identifies the covered date rather than describing a broader period or separate reporting dates. No additional financial figures, line items, or performance measures are provided in the available description.

Pro Forma Balance Sheets

The materials include pro forma combined balance sheets for Glucotrack and Lokahi. These balance sheets present the financial position of the companies on a combined pro forma basis.

The pro forma combined balance sheets are presented as of June 30, 2026. Their stated presentation reflects the merger as though it had occurred on that date, providing the specified basis for reviewing the combined balance-sheet information.

Merger-Date Presentation

The use of a pro forma presentation establishes how the merger is treated for the balance sheets described in the article. The materials show the combined balance sheets using June 30, 2026, as the presentation date. Instead, it explains that the balance sheets reflect the merger as though it had occurred on that date, which defines the presentation described.

Lokahi Management Discussion

The materials also include the related management discussion and analysis for Lokahi. This provides the Lokahi-focused discussion accompanying the financial materials identified in the article.

No specific topics, results, trends, risks, or explanations from Lokahi’s management discussion and analysis are included in the provided text. Accordingly, the article establishes the presence of the discussion without detailing its contents.

Scope of the Materials

The described materials combine transaction context with financial information for Glucotrack and Lokahi. Their stated components are the pro forma combined balance sheets and Lokahi’s related management discussion and analysis. The information therefore centers on what documents are included and how the combined balance sheets are presented.

Peers Moving on This News